Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome
Phase 2
Completed
- Conditions
- Subarachnoid Hemorrhage
- Interventions
- Other: Liberal Red Blood Cell Transfusion StrategyOther: Restrictive Red Blood Cell Transfusion Strategy
- Registration Number
- NCT02483351
- Lead Sponsor
- Ottawa Hospital Research Institute
- Brief Summary
The purpose of this study is to determine the feasibility of conducting a large trial examining the effect on clinical outcome of a liberal red blood cell (RBC) transfusion strategy compared to a restrictive strategy (usual care) in patients with aneurysmal subarachnoid hemorrhage (SAH).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Age ≥18 years old at time of presentation
- First ever episode aneurysmal SAH
- Confirmed aneurysmal SAH diagnosis: as confirmed by treating Neurosurgeon or Neuro-interventionalist and supported by blood in subarachnoid space (demonstrated on cranial imaging or cerebrospinal fluid positive for xanthochromia) that is the result of a ruptured saccular aneurysm (confirmed by cranial imaging - cranial topography or magnetic resonance imaging angiography or catheter angiogram)
- Incident hemoglobin ≤100g/L within 14 days following SAH (defined by first day of hospital presentation)
Read More
Exclusion Criteria
- Physician and or family decision to withdraw/withhold critical care at time of enrolment
- Active bleeding with hemodynamic instability at time of enrolment
- Patients with contra-indication or known objection to blood transfusions
- SAH due to causes other than saccular aneurysm rupture including mycotic, traumatic and dissecting aneurysms, and aneurysms associated with arteriovenous malformations.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Liberal RBC Transfusion Strategy Liberal Red Blood Cell Transfusion Strategy - Restrictive RBC Transfusion Strategy Restrictive Red Blood Cell Transfusion Strategy -
- Primary Outcome Measures
Name Time Method Randomization Rate 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (3)
Vancouver General Hospital
🇨🇦Vancouver, British Columbia, Canada
Hamilton Health Sciences Centre
🇨🇦Hamilton, Ontario, Canada
Shane English
🇨🇦Ottawa, Ontario, Canada